CSIMarket
 


Pluristem Therapeutics Inc  (PSTI)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

PSTI's Operating Income Growth by Quarter and Year

Pluristem Therapeutics Inc's Operating Income results by quarter and year




PSTI Operating Income (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter June - -7.93 -8.78 -6.59
III Quarter March -7.40 -10.30 -9.05 -8.22
II Quarter December -6.37 -8.33 -8.47 -6.65
I Quarter September -7.20 -8.97 -7.44 -6.56
FY   -20.97 -35.53 -33.74 -28.02



PSTI Operating Income third quarter 2020 Y/Y Growth Comment
Pluristem Therapeutics Inc in the third quarter recorded Operating Loss of $ -7.40 millions.

According to the results reported in the third quarter, Pluristem Therapeutics Inc achieved the best Operating Income growth in Biotechnology & Drugs industry. While Pluristem Therapeutics Inc' s Operating Income no change of % ranks overall at the positon no. in the third quarter.

Explain Operating Income growth


PSTI Operating Income ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter June - - - -
III Quarter March - - - -
II Quarter December - - - -
I Quarter September - - - -
FY   - - - -

Financial Statements
Pluristem Therapeutics Inc's third quarter 2020 Operating Income $ -7.40 millions PSTI's Income Statement
Pluristem Therapeutics Inc's third quarter 2019 Operating Income $ -10.30 millions Quarterly PSTI's Income Statement
New: More PSTI's historic Operating Income Growth >>


PSTI Operating Income (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter June - - - -
III Quarter March - - - -
II Quarter December - - - -
I Quarter September - - - -
FY (Year on Year)   - - - -




Operating Income third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Pluristem Therapeutics Inc's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PSTI's III. Quarter Q/Q Operating Income Comment
Recent results of -7.40 millions by Pluristem Therapeutics Inc look even worse if you take a look at Operating Loss -6.37 millions a quarter before.

Within Biotechnology & Drugs industry Pluristem Therapeutics Inc achieved highest sequential Operating Income growth. While Pluristem Therapeutics Inc's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PSTI's III. Quarter Q/Q Operating Income Comment
III. Quarter 2020 Operating Loss of -7.40 millions by Pluristem Therapeutics Inc appear even worse compare to the -6.37 millions in the second quarter.

Within Biotechnology & Drugs industry Pluristem Therapeutics Inc achieved highest sequential Operating Income growth. While Pluristem Therapeutics Inc's Operating Income growth quarter on quarter, overall rank is .


Pluristem Therapeutics Inc's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Dec 31 2016)
Cumulative Operating Income 12 Months Ending $ -28.89 $ -31.79 $ -33.76 $ -35.53 $ -26.78
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment


Pluristem Therapeutics Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment


Pluristem Therapeutics Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Biotechnology & Drugs Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
PSTI's Operating Income Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for PSTI's Competitors
Operating Income Growth for Pluristem Therapeutics Inc's Suppliers
Operating Income Growth for PSTI's Customers

You may also want to know
PSTI's Annual Growth Rates PSTI's Profitability Ratios PSTI's Asset Turnover Ratio PSTI's Dividend Growth
PSTI's Roe PSTI's Valuation Ratios PSTI's Financial Strength Ratios PSTI's Dividend Payout Ratio
PSTI's Roa PSTI's Inventory Turnover Ratio PSTI's Growth Rates PSTI's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Mar 31 2020 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Mar 31 2020
Amedisys Inc -1.02 %$ -1.024 millions
Lemaitre Vascular Inc -1.85 %$ -1.849 millions
Hca Healthcare Inc -2.78 %$ -2.784 millions
Mettler Toledo International Inc -3.03 %$ -3.027 millions
Phibro Animal Health Corp -5.53 %$ -5.534 millions
Utah Medical Products Inc -5.80 %$ -5.803 millions
Pfizer Inc -7.00 %$ -7.000 millions
Illumina Inc -7.35 %$ -7.353 millions
Iqvia Holdings Inc -8.10 %$ -8.095 millions
Brookdale Senior Living Inc -10.57 %$ -10.570 millions
Abiomed Inc -11.22 %$ -11.219 millions
Tenet Healthcare Corp -11.86 %$ -11.860 millions
Bausch Health Companies Inc -13.59 %$ -13.589 millions
Icu Medical Inc -14.21 %$ -14.207 millions
Integra Lifesciences Holdings Corp -16.11 %$ -16.111 millions
U s Neurosurgical Holdings Inc -18.12 %$ -18.121 millions
Orgenesis Inc -18.61 %$ -18.615 millions
Pra Health Sciences Inc -19.74 %$ -19.744 millions
Integrated Biopharma Inc -22.39 %$ -22.393 millions
Immucell Corp -25.79 %$ -25.792 millions
Integrity Applications Inc -26.30 %$ -26.297 millions
Owens and Minor Inc -26.79 %$ -26.790 millions
Quest Diagnostics Inc -29.44 %$ -29.435 millions
Universal Health Services Inc -30.47 %$ -30.473 millions
Community Health Systems Inc -41.80 %$ -41.799 millions
National Vision Holdings Inc -47.79 %$ -47.793 millions
Bristol Myers Squibb Co -50.03 %$ -50.029 millions
Iradimed Corporation -51.30 %$ -51.300 millions
Surgery Partners Inc -52.62 %$ -52.621 millions
Alr Technologies Inc -59.31 %$ -59.308 millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

FSEA's Profile

Stock Price

FSEA's Financials

Business Description

Fundamentals

Charts & Quotes

FSEA's News

Suppliers

FSEA's Competitors

Customers & Markets

Economic Indicators

FSEA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071